Suppr超能文献

急性住院期间及出院后阿片类物质使用障碍的管理:基于病例的综述,阐明急性护理环境中的美沙酮管理规定

Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.

作者信息

Noska Amanda, Mohan Aron, Wakeman Sarah, Rich Josiah, Boutwell Amy

机构信息

Brown University and Warren Alpert Medical School, Providence, RI, USA ; Lifespan Corporation, Rhode Island Hospital and The Miriam Hospital, Providence, RI, USA.

Brown University and Warren Alpert Medical School, Providence, RI, USA.

出版信息

J Addict Behav Ther Rehabil. 2015;4(2). doi: 10.4172/2324-9005.1000138.

Abstract

OBJECTIVE

Treatment with an opioid agonist such as methadone or buprenorphine is the standard of care for opioid use disorder. Persons with opioid use disorder are frequently hospitalized, and may be undertreated due to provider misinformation regarding the legality of prescribing methadone for inpatients. Using a case-based review, this article aims to describe effective management of active opioid withdrawal and ongoing opioid use disorder using methadone or buprenorphine among acutely ill, hospitalized patients.

METHODS

We reviewed pertinent medical and legal literature and consulted with national legal experts regarding methadone for opioid withdrawal and opioid maintenance therapy in hospitalized, general medical and surgical patients, and describe a real-life example of successful implementation of inpatient methadone for these purposes.

RESULTS

Patients with opioid use disorders can be effectively and legally initiated on methadone maintenance therapy or buprenorphine during an inpatient hospitalization by clinical providers and successfully transitioned to an outpatient methadone maintenance or buprenorphine clinic after discharge for ongoing treatment.

CONCLUSIONS

Inpatient methadone or buprenorphine prescribing is safe and evidence-based, and can be used to effectively treat opioid withdrawal and also serves as a bridge to outpatient treatment of opioid use disorders.

摘要

目的

使用阿片类激动剂(如美沙酮或丁丙诺啡)进行治疗是阿片类物质使用障碍的标准治疗方法。患有阿片类物质使用障碍的人经常住院,并且可能由于医疗服务提供者关于为住院患者开具美沙酮的合法性的错误信息而未得到充分治疗。本文通过基于案例的综述,旨在描述在急性病住院患者中使用美沙酮或丁丙诺啡对阿片类物质戒断反应和持续性阿片类物质使用障碍进行有效管理的方法。

方法

我们查阅了相关医学和法律文献,并就住院的普通内科和外科患者使用美沙酮进行阿片类物质戒断治疗和阿片类物质维持治疗的问题咨询了国家法律专家,并描述了为实现这些目的成功实施住院美沙酮治疗的一个实际例子。

结果

患有阿片类物质使用障碍的患者在住院期间可由临床医疗服务提供者合法有效地开始接受美沙酮维持治疗或丁丙诺啡治疗,并在出院后成功过渡到门诊美沙酮维持治疗或丁丙诺啡诊所进行持续治疗。

结论

住院患者开具美沙酮或丁丙诺啡是安全且有循证依据的,可用于有效治疗阿片类物质戒断反应,也是阿片类物质使用障碍门诊治疗的桥梁。

相似文献

10
An anesthesiologist-led inpatient buprenorphine initiative.麻醉医师主导的住院美沙酮计划。
Pain Pract. 2021 Jul;21(6):692-697. doi: 10.1111/papr.12996. Epub 2021 Mar 10.

引用本文的文献

2
Making Sense: Treating Patients with Opioid Use Disorder through the Lens of Game Theory.理解:从博弈论视角治疗阿片类物质使用障碍患者
J Community Hosp Intern Med Perspect. 2024 Jan 12;14(1):80-85. doi: 10.55729/2000-9666.1277. eCollection 2024.
3
Concurrent opioid and alcohol withdrawal management.阿片类药物与酒精戒断的同步管理
Ment Health Clin. 2023 Dec 1;13(6):268-275. doi: 10.9740/mhc.2023.12.268. eCollection 2023 Dec.

本文引用的文献

4
Pharmacological interventions for drug-using offenders.针对吸毒罪犯的药物干预措施。
Cochrane Database Syst Rev. 2013 Dec 19(12):CD010862. doi: 10.1002/14651858.CD010862.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验